[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:globocanestimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] ZEYAULLAH M,ALSHAHRANI A M,AHMAD I.Association of Helicobacter pylori infection and host cytokine gene polymorphism with gastric cancer[J].Can J Gastro Hepatol,2021,2021:8810620.
[3] YAGHOOBI M,MCNABB-BALTAR J,BIJARCHI R,et al.What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis[J].World J Gastro,2017,23(13):2435-2442.
[4] MURPHY G,DAWSEY S M,ENGELS E A,et al.Cancer risk after pernicious anemia in the US elderly population[J].Clin Gastro Hepatol,2015,13(13):2282-2289.e4.
[5] YANG L,KARTSONAKI C,YAO P,et al.The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China:a case-cohort study[J].Lancet Public Health,2021,6(12):e888-e896.
[6] SHIKATA K,DOI Y,YONEMOTO K,et al.Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence:the Hisayama study[J].Am J Epidemiol,2008,168(12):1409-1415.
[7] SMYTH E C,NILSSON M,GRABSCH H I,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
[8] MADDINENI G,XIE J J,BRAHMBHATT B,et al.Diet and carcinogenesis of gastric cancer[J].Curr Opin Gastro,2022,38(6):588-591.
[9] THEODORATOU E,TIMOFEEVA M,LI X,et al.Nature,nurture,and cancer risks:genetic and nutritional contributions to cancer[J].Annu Rev Nutr,2017,37:293-320.
[10] CHIURILLO M A.Role of gene polymorphisms in gastric cancer and its precursor lesions:current knowledge and perspectives in Latin American countries[J].World J Gastro,2014,20(16):4503-4515.
[11] KIM J,CHO Y A,CHOI W J,et al.Gene-diet interactions in gastric cancer risk:a systematic review[J].World J Gastro,2014,20(28):9600-9610.
[12] TSUKINO H,HANAOKA T,OTANI T,et al.hOGG1 Ser326Cys polymorphism,interaction with environmental exposures,and gastric cancer risk in Japanese populations[J].Cancer Sci,2004,95(12):977-983.
[13] VIEL A,BRUSELLES A,MECCIA E,et al.A specific mutational signature associated with DNA 8-oxoguanine persistence in MUTYH-defective colorectal cancer[J].EBioMedicine,2017,20:39-49.
[14] YOUSAF S,KHAN A U,AKRAM Z,et al.Expression deregulation of DNA repair pathway genes in gastric cancer[J].Cancer Genet,2019,237:39-50.
[15] BOITEUX S,RADICELLA J P.The human OGG1 gene:structure,functions,and its implication in the process of carcinogenesis[J].Arch Biochem Biophys,2000,377(1):1-8.
[16] NI M,QIU J,HE W,et al.The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk:evidence from 1180 cases and 2444 controls[J].Eur J Gastro Hepatol,2012,24(6):683-687.
[17] TAKEZAKI T,GAO C M,WU J Z,et al.hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese[J].Int J Cancer,2002,99(4):624-627.
[18] BETHKE L,WEBB E,MURRAY A,et al.Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma[J].Cancer Epidemiol Biomarkers Prev,2008,17(5):1195-1202.
[19] PETRONE I,BERNARDO P S,DOS SANTOS E C,et al.MTHFR C677T and A1298C Polymorphisms in breast cancer,gliomas and gastric cancer:a review[J].Genes(Basel),2021,12(4):587.
[20] WU Y L,HU C Y,LU S S,et al.Association between methylenetetrahydrofolate reductase(MTHFR) C677T/A1298C polymorphisms and essential hypertension:a systematic review and meta-analysis[J].Metabolism,2014,63(12):1503-1511.
[21] FROSST P,BLOM H J,MILOS R,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase[J].Nat Genet,1995,10(1):111-113.
[22] WEI L,NIU F,WU J,et al.Association study between genetic polymorphisms in folate metabolism and gastric cancer susceptibility in Chinese Han population:a case-control study[J].Mol Genet Genomic Med,2019,7(5):e633.
[23] BOCCIA S,HUNG R,RICCIARDI G,et al.Meta-and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk:a huge-GSEC review[J].Am J Epidemiol,2008,167(5):505-516.
[24] GALVÁN-PORTILLO M V,CANTORAL A,OÑATE-OCAÑA L F,et al.Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers[J].Eur J Nutr,2009,48(5):269-276.
[25] MU L N,CAO W,ZHANG Z F,et al.Polymorphisms of 5,10-methylenetetralydrofolate reductase(MTHFR),fruit and vegetable intake,and the risk of stomach cancer[J].Biomarkers,2007,12(1):61-75.
[26] TOWNSEND D M,TEW K D.The role of glutathione-S-transferase in anti-cancer drug resistance[J].Oncogene,2003,22(47):7369-7375.
[27] MA W,ZHUANG L,HAN B,et al.Association between glutathione S-transferase T1 null genotype and gastric cancer risk:a meta-analysis of 48 studies[J].PLoS One,2013,8(4):e60833.
[28] NEGOVAN A,IANCU M,MOLDOVAN V,et al.The interaction between GSTT1,GSTM1,and GSTP1 Ile105Val gene polymorphisms and environmental risk factors in premalignant gastric lesions risk[J].Biomed Res Int,2017,2017:7365080.
[29] CHEN B,ZHOU Y,YANG P,et al.Glutathione S-transferase M1 gene polymorphism and gastric cancer risk:an updated analysis[J].Arch Med Res,2010,41(7):558-566.
[30] NAN H M,PARK J W,SONG Y J,et al.Kimchi and soybean pastes are risk factors of gastric cancer[J].World J Gastro,2005,11(21):3175-3181.
[31] KIM J,KIM H,LEE J,et al.Antioxidant-rich diet,GSTP1 rs1871042 polymorphism,and gastric cancer risk in a hospital-based case-control study[J].Front Oncol,2020,10:596355.
[32] ALZAHRANI A M,RAJENDRAN P.The multifarious link between cytochrome P450s and cancer[J].Oxid Med Cell Longev,2020,2020:3028387.
[33] GHOSHAL U,TRIPATHI S,KUMAR S,et al.Genetic polymorphism of cytochrome P450(CYP) 1A1,CYP1A2,and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection[J].Gastric Cancer,2014,17(2):226-234.
[34] SADEGHI-AMIRI L,BARZEGAR A,NIKBAKHSH-ZATI N,et al.Hypomethylation of the XRE-1383 site is associated with the upregulation of CYP1A1 in gastric adenocarcinoma[J].Gene,2021,769:145216.
[35] HIDAKA A,SASAZUKI S,MATSUO K,et al.CYP1A1,GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese:a nested case-control study within a large-scale population-based prospective study[J].Int J Cancer,2016,139(4):759-768.
[36] ZHAO F,SU J F,LUN S M,et al.Association between polymorphisms in the CYP1A1,CYP2E1 and GSTM1 genes,and smoking,alcohol and upper digestive tract carcinomas in a high-incidence area of northern China[J].Oncol Lett,2019,18(2):1267-1277.
[37] GUENGERICH F P.Cytochrome P450 2E1 and its roles in disease[J].Chem Biol Interact,2020,322:109056.
[38] NA H K,LEE J Y.Molecular basis of alcohol-related gastric and colon cancer[J].Int J Mol Sci,2017,18(6):1116.
[39] SUZUKI S,MUROISHI Y,NAKANISHI I,et al.Relationship between genetic polymorphisms of drug-metabolizing enzymes(CYP1A1,CYP2E1,GSTM1,and NAT2),drinking habits,histological subtypes,and p53 gene point mutations in Japanese patients with gastric cancer[J].J Gastroenterol,2004,39(3):220-230.
[40] SHEN X,ZHANG J,YAN Y,et al.Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population[J].J Toxicol Environ Health A,2009,72(11-12):759-766.
[41] DINCA∨ A L,MELIT L E,MA∨RGINEAN C O.Old and new aspects of hpylori-associated inflammation and gastric cancer[J].Children(Basel),2022,9(7):1083.
[42] NASR R,SHAMSEDDINE A,MUKHERJI D,et al.The crosstalk between microbiome and immune response in gastric cancer[J].Int J Mol Sci,2020,21(18):6586.
[43] MILNE A N,CARNEIRO F,O'MORAIN C,et al.Nature meets nurture:molecular genetics of gastric cancer[J].Hum Genet,2009,126(5):615-628.
[44] KIM J,KIM Y,LEE K A.Ethnic differences in gastric cancer genetic susceptibility:allele flips of interleukin gene[J].World J Gastro,2014,20(16):4558-4565.
[45] SULTANA Z,BANKURA B,PATTANAYAK A K,et al.Association of interleukin-1 beta and tumor necrosis factor-alpha genetic polymorphisms with gastric cancer in India[J].Environ Mol Mutagen,2018,59(7):653-667.
[46] WANG F,XUE Y,FU L,et al.Extraction,purification,bioactivity and pharmacological effects of capsaicin:a review[J].Crit Rev Food Sci Nutr,2022,62(19):5322-5348.
[47] LÓPEZ-CARRILLO L,CAMARGO M C,SCHNEIDER B G,et al.Capsaicin consumption,helicobacter pylori CagA status and IL1B-31C > T genotypes:a host and environment interaction in gastric cancer[J].Food Chem Toxicol,2012,50(6):2118-2122.
[48] WANG X Q,TERRY P D,CHENG L,et al.Interactions between pork consumption,CagA status and IL-1B-31 genotypes in gastric cancer[J].World J Gastro,2014,20(25):8151-8157.
[49] ZHENG Z,HUANG G,GAO T,et al.Epigenetic changes associated with interleukin-10[J].Front Immunol,2020,11:1105.
[50] WANG X,YANG F,XU G,et al.The roles of IL-6,IL-8 and IL-10 gene polymorphisms in gastric cancer:a meta-analysis[J].Cytokine,2018,111:230-236.
[51] KUO W H,HUANG C Y,FU C K,et al.Effects of interleukin-10 polymorphisms and smoking on the risk of gastric cancer in Taiwan[J].In Vivo,2014,28(5):967-971.
[52] MARTÍNEZ-CAMPOS C,TORRES-POVEDA K,CAMORLINGA-PONCE M,et al.Polymorphisms in IL-10 and TGF-β gene promoter are associated with lower risk to gastric cancer in a Mexican population[J].BMC Cancer,2019,19(1):453.
[53] KULMAMBETOVA G,SHTEFANOV I,AITKULOVA A,et al.Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population[J].Bosn J Basic Med Sci,2020,20(4):539-546.
[54] AL-NAKKASH L,KUBINSKI A.Soy isoflavones and gastrointestinal health[J].Curr Nutr Rep,2020,9(3):193-201.
[55] WANG Y,GUO J,YU F,et al.The association between soy-based food and soy isoflavone intake and the risk of gastric cancer:a systematic review and meta-analysis[J].J Sci Food Agric,2021,101(13):5314-5324.
[56] KO K P,PARK S K,CHO L Y,et al.Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk[J].J Nutr,2009,139(5):1008-1012. |
